<DOC>
	<DOCNO>NCT01269671</DOCNO>
	<brief_summary>IND application submit FDA November 17th .</brief_summary>
	<brief_title>Efficacy Combination Therapy v Placebo Pediatric Functional Abdominal Pain</brief_title>
	<detailed_description />
	<mesh_term>Irritable Bowel Syndrome</mesh_term>
	<mesh_term>Abdominal Pain</mesh_term>
	<mesh_term>Dyspepsia</mesh_term>
	<mesh_term>Melatonin</mesh_term>
	<mesh_term>Peppermint oil</mesh_term>
	<mesh_term>Simethicone</mesh_term>
	<criteria>To participate study , child/teen must patient FAP Clinic/GI Clinic Division Gastroenterology Children 's Hospital Wisconsin , parent legal guardian willing participate . Children age 818 year eligible inclusion study . Children parent nonEnglish speaking , parent and/or child cognitive delay precludes comprehension completion questionnaire exclude participate registry .</criteria>
	<gender>All</gender>
	<minimum_age>8 Years</minimum_age>
	<maximum_age>18 Years</maximum_age>
	<verification_date>August 2015</verification_date>
	<keyword>Functional Abdominal Pain</keyword>
	<keyword>Irritable Bowel Syndrome</keyword>
	<keyword>IBS</keyword>
	<keyword>Functional Dyspepsia</keyword>
	<keyword>Melatonin</keyword>
	<keyword>Simethicone</keyword>
	<keyword>Peppermint Oil</keyword>
	<keyword>mentharil</keyword>
	<keyword>functional bowel disorder</keyword>
	<keyword>quality life</keyword>
</DOC>